Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Xilio Therapeutics, Inc. (XLO)

NASDAQ

$9.05

$+0.03

(+0.33%)

Previous Close: ⁦$9.02⁩

Market Closed

Xilio Therapeutics, Inc. (XLO) Live Price Chart

Last updated: ⁦2026-09-06 12:37:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Xilio Therapeutics, Inc. (XLO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $9.05, with a market capitalisation of $58.17M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.47 to $12.74. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$58.17M
Open	$9.34
Day's High	$391.30
Day's Low	$6.47
Previous Close	$9.02
Volume	7.43K
Average Volume	--
P/E Ratio	--
52-Week High	$12.74
52-Week Low	$6.47
Dividend Yield	--
Earnings Date	--

Xilio Therapeutics, Inc. (XLO) Latest Closing Stock Price

Xilio Therapeutics, Inc. (XLO) last closed at $9.02 as of 2026-09-04 23:31:00, unchanged from the previous close of $9.02.

During the latest regular trading session, XLO traded between $6.47 and $391.30, with a volume of 7.43K shares. The closing price was near the lower end and near the middle of its 52-week range.

Xilio Therapeutics, Inc. (XLO) 7-Day Stock Price Change

Over the past seven days, Xilio Therapeutics, Inc. (XLO) moved from $9.00 to $9.05, representing a gain of 0.51% ($0.05).

The stock traded between $8.82 and $9.34 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 11.04 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

XLO 52-Week Price Position

Position in Range: 41.1%

52W Low$6.47

52W High$12.74

XLO is currently trading at $9.05, placing it 41.1% of the way from its 52-week low of $6.47 to its 52-week high of $12.74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Xilio Therapeutics, Inc. (XLO)?

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Xilio Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	76
Exchange	NASDAQ
Company Website	https://www.xiliotx.com

How to Buy Xilio Therapeutics, Inc. (XLO) Stock on MEXC

Eligible investors can buy real shares of Xilio Therapeutics, Inc. (XLO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for XLO and Place Your Order

Open the RealStocks trading page and search for XLO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Xilio Therapeutics, Inc. (XLO) share price today?

Xilio Therapeutics, Inc. (XLO) is currently trading at $ 9.05, up 0.29% ($0.03) from the previous close of $ 9.02. Intraday prices update in real time during regular trading hours.

2.Is XLO stock going up or down today?

As of 2026-09-04 23:31:00, XLO is trading at $ 9.05, up 0.29% ($0.03) from its previous close of $ 9.02. The stock has traded between $ 6.47 and $ 391.30 during today’s regular session. Past price movements do not guarantee future results.

3.What is XLO pre-market price?

As of 2026-09-04 23:31:00, XLO is trading at $ 9.34 in pre-market trading, up 3.55% ($0.32) from the previous close of $ 9.02. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is XLO after-hours price?

As of 2026-09-04 23:31:00, XLO is trading at $ 9.00 in after-hours trading, down 0.22% ($0.02) from the regular-session close of $ 9.02. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is XLO stock trading now?

XLO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does XLO sit relative to its 52-week high and low?

Over the past 52 weeks, XLO has traded between a low of $ 6.47 and a high of $ 12.74. At $ 9.05, the stock is positioned 41.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Xilio Therapeutics, Inc. in?

Xilio Therapeutics, Inc. (XLO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Xilio Therapeutics, Inc.'s market capitalisation and where is it listed?

Xilio Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 58.17M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is XLO valued in terms of P/E ratio and EPS?

XLO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.32. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Xilio Therapeutics, Inc. pay a dividend?

Xilio Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.